Please login to the form below

Not currently logged in
Email:
Password:

somapacitan

This page shows the latest somapacitan news and features for those working in and with pharma, biotech and healthcare.

Versartis crashes as VELOCITY trial veers off track

Versartis crashes as VELOCITY trial veers off track

candidate. It’s worth noting however that hGH behemoth Novo Nordisk also has a once-weekly candidate called somapacitan in phase III in Japan and Europe, although that project seems to

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Reaching patients and HCPs during the pandemic Reaching patients and HCPs during the pandemic

    Self-administered injectables, such as Novo Nordisk’s recently approved therapy for adult growth hormone deficiency (GHD), Sogroya (somapacitan), and Novartis’ much-hyped MS treatment, Kesimpta (ofatumumab), will be tested in

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
ahair@onyxhealth.com

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...